Ask teams why they switched A/B testing tools and the Google Optimize story — the free tool that sunset and sent everyone scrambling — barely comes up anymore; that migration is done. What comes up instead is quieter and more structural. It's a slow-burn condition tolerated for a year or more — an enterprise or suite-tier tool that was over-bought and under-used, a testing program gated on one small team, a depth-versus-simplicity tension between the value tool and the heavy suite — meeting a sharp event that forces the decision: a renewal that can't be justified, a replatform that resets the stack, or an org change that hands experimentation to product and engineering. And the destination now forks two ways, which is what makes 2026 different: teams either trade down to a marketer-run value tool, or move up to a developer-owned experimentation platform. For where the Optimize refugees originally landed and how buyers rate the platforms, see A/B testing after Optimize; for the buyer-side lessons, what experimentation buyers wish they'd known.
The pressure that builds
These are the slow-burn conditions teams live with — often for a year or more — before anything forces the issue. On their own they rarely start a switch; they set the stage for one.
Over-bought and under-used — the enterprise tier nobody fills
The most common experimentation pressure, and it's about utilization, not quality. A team buys the enterprise or suite tier — full personalization, server-side, the whole platform — then runs a handful of tests a quarter against a license priced for a testing factory. The gap between what's paid and what's used widens every renewal. Optimizely is the most-rated experimentation tool in our corpus and sits around a solid 7.3/10 overall, yet it carries a long dissatisfied tail: a meaningful share of buyers rate it a five or below, and cost against actual usage is the recurring reason. It's rarely that the tool is bad — it's that the team bought more platform than its testing cadence can justify, and eventually someone does the math.
Named in this context: Optimizely · Adobe Target · Sitecore
Testing velocity gated on one team — and often on engineering
The bottleneck pressure. In many stacks experimentation lives with a single small CRO or optimization team, and anything beyond a simple visual test — server-side logic, a personalized flow, anything touching the product — needs engineering time that's always scarce. The result is a backlog: ideas queued for months, a test cadence far below what leadership expects, and a growing sense that the tool, or the setup around it, is the reason the program is slow. Buyers describe wanting to democratize experimentation — to let more people run tests without a specialist or a developer in the loop for every one. When velocity stalls, teams start looking for a tool that either makes marketer-run testing effortless or moves experimentation to where the engineers already are.
Named in this context: Optimizely · VWO · AB Tasty
The depth-versus-simplicity math stops adding up
The pressure that sets the direction of the switch. On the value-tool side, teams that started with a lightweight or native testing tool sometimes outgrow it — they want server-side testing, deeper targeting, real statistics — and find it shallow. On the enterprise-suite side, teams paying for a heavy platform question whether they use enough of it to justify the weight and cost, especially when a simpler tool or the testing built into their commerce platform would cover most of what they actually run. The same tension pushes teams opposite ways: toward more capability, or toward less overhead. Which way you go depends on who owns experimentation and how sophisticated the tests really need to be — and this pressure is the one that decides the destination.
Named in this context: AB Tasty · VWO · Optimizely
The event that fires the decision
These are the sharp triggers — the ones teams can date. Each turns a tolerated situation into an active switch, and each tends to arrive when the budget or the stack is already in motion.
A renewal or cost review that can't be justified against usage
The most common trigger, and the flip side of the over-bought pressure. A renewal lands, or a stack-cost review begins, and someone asks the uncomfortable question: how many tests did we actually run against this license? When the answer is a handful, the enterprise tier becomes an obvious cut. Buyers describe explicitly optimizing tech-stack utilization and cost efficiency, and reconsidering tools whose spend outran their use. Experimentation platforms are especially exposed here because usage is measurable — test count is a number, and a low one against a high invoice is hard to defend in a budget cycle. A renewal quote on a tool you were already under-using is one of the clearest reasons a switch gets funded.
Named in this context: Optimizely · Adobe Target
A replatform resets the whole experimentation layer
A big external trigger. When a brand replatforms its store — a common move we hear is Magento to Shopify — or overhauls its CMS, the experimentation tool is dragged into the same decision, because testing runs against the front end and the delivery stack the replatform is replacing. Buyers describe migrating platforms and re-evaluating CRO and testing tooling as part of the same project, sometimes trying newer AI-driven testing tools in the process. The migration is the moment a tolerable arrangement becomes a live choice: integrations have to be rebuilt anyway, so the question shifts from "keep or leave" to "what should the testing layer be on the new stack." If your commerce platform is moving, your testing tool is in scope.
Named in this context: Optimizely · VWO · AB Tasty
Product and engineering take over experimentation
The trigger that's reshaping the category. As experimentation matures, it increasingly moves out of marketing and into the product organization — run by product managers and engineers, tied to feature flags, and delivered server-side. When that org change happens, the marketer-owned client-side tool no longer fits how the work is done, and teams consolidate testing onto a platform that gates both features and experiments at once. Buyers describe running experimentation on feature-flagging and product-analytics platforms — Statsig, LaunchDarkly, Eppo, GrowthBook — and driving experimentation and feature monetization through product and engineering rather than a marketing team. This isn't a like-for-like tool swap; it's experimentation changing owners, and the old tool leaves with the old owner.
Named in this context: Statsig · LaunchDarkly · Eppo · GrowthBook
Where they go — the two-direction fork
Here's what makes 2026 different from the Optimize scramble: the switch now runs two very different directions. The same pressures push some teams toward a simpler marketer-run tool and others toward a developer-owned platform, and which direction a team takes is set by who owns experimentation.
Leave the heavy suite for a lighter client-side tool marketing can run without engineering, or the testing built into the commerce platform. The destination for teams where marketing designs and ships the tests, and cost and simplicity win.
Move experimentation into the product org, tied to feature flags and delivered server-side, owned by product and engineering. The destination for teams where experimentation has become an engineering practice, not a marketing one.
The counter-current: A/B testing is welded to the platform around it
The pressure to switch is real, but it collides with a fact that keeps a lot of dissatisfied teams exactly where they are: on the enterprise tier, A/B testing is rarely a standalone product. It's welded to a wider digital-experience platform — the CMS, personalization, content, and delivery tooling — so "switching your test tool" often means switching your content platform, a far heavier project than the rating alone suggests. That inertia is why teams that rate their experimentation tool poorly still renew it. There's a second trap underneath: buyers repeatedly find the tool was rarely what held the program back — a thin test roadmap, tests without the traffic to reach significance, and no owner for the practice travel with you to any platform. The teams that get this right separate the two questions. Fix the process first — a real backlog, powered sample sizes, a clear owner — and only then decide whether the tool, and who runs it, actually needs to change. A switch made to escape a slow program usually just re-buys the same disappointment on a new invoice.
What this means if you're weighing a switch
Three checks before you move. First, decide the direction from who owns experimentation, not from a vendor shortlist: if marketing runs the tests, a client-side value tool is simpler; if product and engineering do, a dev-owned platform tied to feature flags matches how the work already happens. Second, be honest about utilization before you blame the tool — if you're running a handful of tests against an enterprise license, the fix might be a lighter tool, but it might also be a real testing practice. Third, check what your test tool is welded to: if it's part of your CMS or DXP, price the switch as a platform migration, not a tool swap. For where the platforms rank and how the Optimize exit played out, see A/B testing after Optimize; for the buyer-side lessons, what experimentation buyers wish they'd known.
Common questions
Why do teams switch A/B testing tools?
Rarely because testing stopped mattering — and, in 2026, rarely because of the old Google Optimize sunset, which the market absorbed years ago. It's a slow-burn pressure meeting a sharp trigger. The pressures build over time: an enterprise or suite-tier tool that was over-bought and under-used, so a handful of tests a quarter carry a heavy license; testing velocity gated on one small team or on engineering; and a depth-versus-simplicity tension where the value tool feels shallow and the enterprise suite feels heavy. What fires the switch is a sharp event: a renewal or cost review that can't be justified against usage, a replatform that resets the experimentation layer, or an org change that moves experimentation out of marketing and into product and engineering. And the destination now forks two ways — trade down to a marketer-run value tool, or move up to a developer-owned experimentation platform tied to feature flags and server-side delivery.
Should we move to a developer-owned platform like Statsig, LaunchDarkly, or Eppo, or stay on a marketer tool like VWO or AB Tasty?
It depends on who owns experimentation and where your tests run. A marketer-run client-side tool — VWO (about 7.3/10), AB Tasty (about 7.8), or the testing built into your commerce platform — fits teams where marketing designs and ships tests against the front end without waiting on engineering; it's fast for visual and content experiments and needs little developer time. A developer-owned platform like Statsig, LaunchDarkly, Eppo, or GrowthBook fits teams where experimentation has moved into the product organization: tests are tied to feature flags and delivered server-side, engineers and product managers own the roadmap, and one system gates both features and experiments. Buyers increasingly describe this shift. The honest split is who runs the tests: if marketing does, a client-side tool is simpler; if product and engineering do, the dev-owned platform matches how the work already happens.
Why do teams leave Optimizely, and is it worth keeping?
Optimizely is the most-rated experimentation tool in our corpus and sits around 7.3/10 overall — a solid middle — but it carries a long dissatisfied tail: a meaningful share of buyers rate it a five or below, most often over cost against actual usage. The common story is a team that bought the enterprise or DXP tier, ran far fewer tests than the license assumed, and then couldn't justify the renewal. There's a catch that cuts the other way: on the enterprise tier, A/B testing is often welded to the wider digital-experience platform — the CMS, personalization, and content tooling — so leaving the test product can mean leaving the content platform too, and that inertia is why many low-raters stay put. It's worth keeping if you genuinely use the suite it's part of and run enough experimentation to earn the tier; worth leaving if you're paying suite prices for a handful of tests, in which case a lighter value tool or a dev-owned platform usually fits better.
This is the aggregate. Your stack is specific.
Weighing an experimentation-tool switch right now? Do a 15-minute interview about your program and what's pushing you, and get this personalized — whether you're really trading down, moving up to a dev-owned platform, or fixing a process the tool was never the cause of, and where peers your size landed.
Get my personalized briefNo password needed · your interview is anonymized before it ever informs a page like this one.